Predicting the Pathologic Complete Response After Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer

BACKGROUND: In the PURE-01 study (NCT02736266), we aimed to evaluate the ability to predict the pathologic complete response (pT0N0) after pembrolizumab by using clinical and tumor biomarkers. METHODS: In an open-label, single-arm, phase 2 study, 3 courses of 200 mg pembrolizumab preceding radical c...

Full description

Saved in:
Bibliographic Details
Published in:J Natl Cancer Inst
Main Authors: Bandini, Marco, Ross, Jeffrey S, Raggi, Daniele, Gallina, Andrea, Colecchia, Maurizio, Lucianò, Roberta, Giannatempo, Patrizia, Farè, Elena, Pederzoli, Filippo, Bianchi, Marco, Colombo, Renzo, Gandaglia, Giorgio, Fossati, Nicola, Marandino, Laura, Capitanio, Umberto, Deho’, Federico, Ali, Siraj M, Madison, Russell, Chung, Jon H, Salonia, Andrea, Briganti, Alberto, Montorsi, Francesco, Necchi, Andrea
Format: Artigo
Language:Inglês
Published: Oxford University Press 2020
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7781448/
https://ncbi.nlm.nih.gov/pubmed/32516377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djaa076
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items